Proposal for detection of 2019-nCoV nucleic acid in clinical laboratories
10.3760/cma.j.issn.1009-9158.2020.0003
- VernacularTitle: 新型冠状病毒核酸检测临床实验室操作规范的建议
- Author:
Yongqing TONG
1
;
Ming WANG
;
Wanzhou XU
;
Bin QIAO
;
Hongyun ZHENG
;
Siqing MEI
;
Xiaoyun HE
;
Pingan ZHANG
;
Yan LI
Author Information
1. Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, China
- Publication Type:Journal Article
- Keywords:
Coronavirus;
RNA, viral;
Polymerase chain reaction;
Laboratories, hospital;
Medical laboratory science;
Benchmarking;
Containment of biohazards
- From:
Chinese Journal of Laboratory Medicine
2020;43(0):E003-E003
- CountryChina
- Language:Chinese
-
Abstract:
In December, the outbreak of a novel coronavirus (2019-nCoV) in Wuhan, China, has attracted extensive global attention. On January 20, 2020,the Chinese health authorities upgraded the coronavirus to a Class B infectious disease in the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, and considered it as Class A infectious diseases in disease control and prevention. On January 22, 2020, the 2019-nCoV nucleic acid detection test was listed as the diagnostic criteria in the "guidelines for diagnosis and treatment of pneumonia due to 2019-nCoV (Trial Version 2)" . Therefore, standardizing the operation process of the 2019-nCoV nucleic acid detection in clinical laboratories has become a top priority. It is of paramount importance to establish standard protocols for detection of the 2019-nCoV nucleic acids in clinical laboratories to improve the reliability of the results and ensure the biosafety of laboratory personnel.
